Guidelines for the management of basal cell carcinoma. British Association of Dermatologists

Br J Dermatol. 1999 Sep;141(3):415-23. doi: 10.1046/j.1365-2133.1999.03033.x.

Abstract

These guidelines on the management of basal cell carcinoma have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Carcinoma, Basal Cell / diagnosis
  • Carcinoma, Basal Cell / surgery*
  • Carcinoma, Basal Cell / therapy
  • Fluorouracil / therapeutic use
  • Humans
  • Interferon Type I / therapeutic use
  • Palliative Care
  • Phototherapy
  • Recombinant Proteins
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / surgery*
  • Skin Neoplasms / therapy

Substances

  • Antimetabolites, Antineoplastic
  • Interferon Type I
  • Recombinant Proteins
  • Fluorouracil